‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code


Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

The maker of slimming jab Wegovy was facing crises on multiple fronts this weekend, with the UK medicines regulator announcing a review of its operations at the same time as an investigation is under way into the approval of its injections for NHS use.

In the last few days, Novo Nordisk has also been suspended from its pharmaceutical trade body and seen the loss of a key partnership with the Royal College of Physicians (RCP), which said on Friday that it had cut ties with the company after breaches of industry code.

Continue reading...

Continue reading at Guardian »

Pharmaceuticals industry, Business, The Observer/Anthony Burgess Prize for Arts Journalism, Obesity, Society, NHS, National Institute for Health and Care Excellence, Health


No comments on this item Please log in to comment by clicking here